APAysel Pehlivanli

Aysel Pehlivanli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aysel Pehlivanli has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Knowledge, Attitudes, and Practice Behaviours Regarding Intravenous Drug Incompatibilities Among Intensive Care Unit Healthcare Professionals: A Multicenter Cross‐Sectional Study

    by Aysel Pehlivanli, Cigdem Ozgun, Abdikarim Abdi, Bilgen Basgut, Arif Tanju Ozcelikay, Mustafa Necmettin Unal

    Objective: This study aimed to evaluate the knowledge, clinical attitudes, and behavioural responses of healthcare professionals regarding IV drug incompatibility, identify gaps between knowledge and practice, and determine areas for improvement. Methods: A cross‐ sectional online survey was conducted in Türkiye among physicians and nurses with intensive care unit (ICU) experience. Data were collected using a structured questionnaire assessing knowledge levels, attitudes, and perceived barriers. Results: A total of 380 healthcare professionals participated. Overall knowledge levels were moderate to high (mean score: 10.4 ± 2.2). Most participants recognised the serious clinical consequences of IV drug incompatibility and emphasised its importance for patient safety. However, adherence to standard guidelines was limited, and time constraints and workload were reported as major barriers. Multivariate analysis revealed that nurses had significantly lower knowledge scores than physicians (β = −1.64; 95% CI: −2.15 to −1.13). Despite high awareness, knowledge was not consistently translated into practice. Conclusion: These findings highlight the importance of system‐level interventions rather than solely individual‐focused training. However, the findings should be interpreted in light of the cross‐sectional design, convenience sampling, and reliance on self‐reported data.

  • Open Access

    Antimicrobial stewardship practices in the intensive care unit: a pre–post interventional study

    by Aysel Pehlivanlı, Tuğba Yanık Yalçın, Fatma İrem Yeşiler, Nuran Sarı, Helin Şahintürk, Özlem Kurt Azap, Pınar Zeyneloğlu, Bilgen Başgut

    Objective: This study aims to assess the frequency of drug-related problems (DRPs) related to antimicrobial drugs in the ICU and to examine changes in the use of antibiotics in the ‘Reserve’ group of the World Health Organization (WHO) AWaRe classification during the antimicrobial stewardship (AMS) team intervention, including the clinical pharmacist. Methods: In this single-center intervention study, the pre-intervention period between November 2021 and August 2022 and the post-intervention period between November 2022 and August 2023 were evaluated. In the post-intervention period, a clinical pharmacist was also included in the AMS team. Post-intervention medication-related problems (DRPs) were categorized using only the “problem” and “cause” domains of the Pharmaceutical Care Network Europe (PCNE) V9.1 classification system. Additionally, recommendations and their acceptance rates were recorded. The antibiotic use density of the ‘Reserve’ group, defined in the WHO AWaRe classification, was evaluated in terms of days of therapy (DOT) per 1000 patient-days. Results: After the intervention, 175 DRPs were detected in 67.1% of 173 patients; 70% were related to antimicrobial drugs. The 90.1% of the interventions suggested by the clinical pharmacist were evaluated and accepted by infectious diseases and intensive care specialists. The total use of “Reserve” group antibiotics decreased, but not significantly; significant decreases were observed for some agents such as linezolid and daptomycin. Conclusion: Multidisciplinary antimicrobial stewardship practices involving the clinical pharmacist can contribute to the prevention of antimicrobial resistance development by facilitating the detection and solution of DRPs, especially by reducing the use of ‘Reserve’ group antimicrobials.

  • Open Access

    Use of the Pharmacy First service in England in the first 12 months: geographic variation and health system context

    by Weiyao Meng, Kimberley Sonnex, Aysel Pehlivanli, Thomas Allen, Elizabeth Dolan, Rebecca Glover, James Goulding, Hannah Higgins, Nicholas Mays, Amelia Taylor, et al.

    Objectives: The Pharmacy First (PF) service was introduced across England from 31 January 2024 to expand the clinical role of community pharmacies and improve access to primary care. This paper describes use of PF in its first 12 months, in terms of uptake, access routes, consultation outcomes, geographic variations, service costs and antimicrobial supply. Methods: A descriptive analysis of all PF consultations submitted for payment to NHS Business Services Authority in England between 31 January 2024 and 31 January 2025. Pharmacy-level consultation data were linked to national data on population, location and pharmacy characteristics. PF use was examined using population-standardised consultation rates and consultations per pharmacy. Results: During the first year of implementation, 2,205,731 PF consultations were recorded as delivered across 11,349 pharmacies, with payment of £123 million to pharmacies. Uptake increased steadily over time. Most consultations were for acute sore throat (33%) and uncomplicated urinary tract infection (27%), with corresponding antibiotics, phenoxymethylpenicillin and nitrofurantoin being the most supplied. Most people self-referred (74%) into the service, with 95% of consultations managed without onward referral. Substantial geographic variation was observed. Northern regions had higher use based on the eligible population. The South East and Midlands had higher activity per pharmacy. London showed a distinct pattern, with higher self-referral into the service, lower medication supply and higher referral to other healthcare services. Higher consultation volume was weakly associated with pharmacy characteristics, including opening hours, pharmacy type and retail setting, and local context, in terms of socio-economic and geographic factors. Conclusions: PF had immediate uptake and is operating primarily as a direct-access model for common acute conditions. Findings suggest that PF is contributing to improved access to care and may shift demand away from general practice. However, the service uptake appears to be shaped by geographic location, proximity to other healthcare services and pharmacy characteristics.


  • Open Access

    Antimicrobial Stewardship in Transplant Recipients: A Scoping Review of Interventions, Outcomes, and Policy Implications

    by Aysel Pehlivanlı, Beril Kadıoğlu-Yaman, Hilal Akyel, Beyza Begüm Öztürk, Nuran Sarı, Bilgen Başgut

    Objective: This scoping review aimed to characterize antimicrobial stewardship (AMS) interventions in transplant recipients, compare antibacterial, antifungal, and antiviral stewardship strategies, summarize clinical and economic outcomes, and identify knowledge gaps relevant to health policy. Materials and Methods: The study was conducted according to the Joanna Briggs Institute methodology and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines. Original research articles published between January 2015 and March 2025 were identified through searches of the PubMed, Scopus, and Web of Science databases. Data were synthesized using thematic analysis. Results: Fifteen studies published between 2017 and 2025 were included. Thematic analysis categorized the interventions into the following domains: intervention structure, individualized strategies, diagnostic management, clinical and economic outcomes, comparative findings by population and transplant type, and implementation barriers. All studies included an antibacterial stewardship component (100%), whereas antifungal (20%) and antiviral (7%) interventions were comparatively limited. Interventions were primarily implemented as guideline-based optimization and prospective audit-and-feedback models. Infectious disease specialists participated in 87% of the studies, while clinical pharmacists were involved in 33%. Clinical effects were predominantly reported using process indicators. A reduction in antimicrobial treatment duration (47%) and improved guideline adherence (33%) were the most frequently reported outcomes. Studies evaluating mortality and graft survival were limited (27%), and most did not demonstrate significant differences. Economic outcomes were reported in 73% of the studies, with program-level cost reductions ranging from 20% to 40%. The most common implementation barriers were high resource requirements and heterogeneity of guidelines. Conclusion: Antimicrobial stewardship practices in transplant recipients are primarily focused on antibacterial management and are associated with improvements in short-term process indicators. However, evidence regarding long-term clinical outcomes and antifungal and antiviral stewardship practices remains limited. Developing transplant-specific, multidisciplinary, and sustainable AMS models is essential for antimicrobial resistance control and patient safety in this high-risk population. Keywords: Antimicrobial stewardship, transplantation, solid organ transplantation, hematopoietic stem cell transplantation, policy, scoping review

  • Open Access

    Exploring determinants in deciding the optimal antimicrobial dose in patients undergoing CRRT: a mixed-methods study

    by Tuğba Yanık Yalçın, Aysel Pehlivanlı, Fatma İrem Yeşiler, Helin Şahintürk, Özlem Azap, Hande Arslan, Bilgen Başgut, Pınar Zeyneloğlu

    Antimicrobial dosing in patients undergoing continuous renal replacement therapy (CRRT) is a clinical challenge. The study aimed to investigate the factors that influence appropriate antimicrobial doses in CRRT and to address gaps in current knowledge and practice. The mixed-method design involved two phases. For the quantitative phase, infectious disease, intensive care, and clinical pharmacy professionals completed a questionnaire assessing demographics and practice details, as well as their knowledge, attitudes, and practices on antibiotic dosing in CRRT. In the qualitative phase, online focus groups were conducted using a question schedule based on the Theoretical Domains Framework to explore challenges and expectations. A structured questionnaire was completed by 160 participants, most of whom were infectious disease specialists (61.3%) with over 10 years of experience (38.8%). Despite a high knowledge level of antimicrobial dosing during CRRT, the sieving coefficient was unclear at 74.4%. Although 96.3% reported adjusting doses, 78.8% lacked institutional guidelines, and 68.1% did not monitor drug levels. CRRT experience positively influenced knowledge and attitude scores, and different dosing practices were reported for meropenem, piperacillin-tazobactam, and vancomycin. Qualitative findings highlighted the need for standard guidelines and CRRT-specific training. Multidisciplinary collaboration and real-time monitoring of therapeutic drugs were emphasized. This study identifies key gaps in knowledge and practice regarding antimicrobial dosing in CRRT. Addressing these gaps requires targeted training programs, real-time drug monitoring, and the development of evidence-based dosing guidelines to enhance patient safety and antimicrobial efficacy. Future research should evaluate the impact of these interventions on clinical outcomes.


  • Open Access

    The Definition, Prevalence, and Risk Factors of Augmented Renal Clearance in Adult Patients on Antimicrobial Therapy: A Scoping Review

    by Hasan Memis, Ahmet Cakır, Aysel Pehlivanli, Bilgen Basgut

    Antibiotic resistance has become a significant public health concern, primarily due to irrational antibiotic use. Healthcare and antimicrobial stewardship depend on using antibiotics correctly for several reasons. In the first place, adhering to the prescribed dosage ensures that the body receives the right amount of antibiotics to treat


  • Open Access

    The nature of inquiries and responses in clinical pharmacy teleconsultation service: a retrospective study from Türkiye

    by Aysel Pehlivanli, Hilal Akyel, Beril Kadioglu-Yaman, Bilgen Basgut

    Clinical pharmacy services play a critical role in enhancing patient care and effectively managing drug-related problems in hospital settings. Clinical pharmacy teleconsultation services have demonstrated promising results in improving medication safety, reducing adverse drug reactions, and supporting physicians in clinical decision-making. The aim of this study is to examine the integration and implementation of a clinical pharmacy teleconsultation service at a university hospital in Türkiye. This retrospective study evaluated pharmacist-led teleconsultation services conducted between June 2023 and October 2024. Data on patient demographics, inquiry types, medication-related problems, and pharmacist recommendations were collected. There were 54 teleconconsultations recorded, with the majority occurring in haematology (42.6%), nephrology (11.1%), and general surgery (11.1%). A majority of teleconconsultations involved reviews of drug interaction (33.3%), polypharmacy medication and potential deprescribing (20.4%), and adverse drug reactions (20.4%). Eighty-seven percent of teleconconsultations were completed within 24 h, with an average of 3 recommendations per consult. The recommendations were all accepted by the physicians. A clinical pharmacy teleconsultatiton service at Başkent University Ankara Hospital has indicated potential to support medication management and foster interdisciplinary collaboration, as reflected by the high rate of recommendation acceptance. There is a need for further research in Türkiye to determine the long-term effects of clinical pharmacy teleconsultation on patient outcomes and sustainability.


  • Open Access

    Pharmacy practice and policy research in Türkiye: a systematic review of literature

    by Gizem Gülpınar, Aysel Pehlivanlı, Zaheer-Ud-Din Babar

    In recent decades, there has been an interest in clinical pharmacy practice in Türkiye with emerging studies in this area. Despite the recent emergence of diverse pharmacy practice studies in Türkiye, a comprehensive assessment of overall typology of studies and impact has not been conducted thus far. This systematic review aims to document and assess pharmaceutical policy and practice literature published within the last 5 years in Türkiye. The other aim is to summarise the expected impact of published studies on policy and practice research. The systematic review was conducted according to the guidelines described in the PRISMA Statement. A comprehensive search approach, incorporating Medical Subject Headings (MeSH) queries and free-text terms was employed to locate pertinent literature related to pharmacy practice and policy in Türkiye. The search covered the period from January 1, 2019, to January 1, 2024, and involved electronic databases including PubMed, Medline Ovid, Scopus, ScienceDirect, Springer Link, PlosOne, and BMC. In the final grouping, 73 articles met the inclusion criteria and were selected for this review. Among the quantitative studies, majority studies were cross-sectional survey studies. Through the rigorous thematic content analysis seven research domains were developed from the selected literature: drug utilisation and rational drug use, the emerging role of pharmacist, access to medicines and generic medicines, community pharmacy practice, pharmacovigilance/adverse drug reactions, and pharmacoeconomic studies. The pharmacist role is evolving; however, several challenges remain in fully realising the potential of pharmacists. These include regulatory barriers, limited public awareness of pharmacists' expanded roles, workforce capacity issues, and the need for ongoing professional development and training. Research studies are needed in the areas of generic prescribing, medicine adherence, intervention studies in community and hospital pharmacy practice, and on pharmacoeconomics and pharmacovigilance.


  • A qualitative study exploring self-management behaviour of patients with chronic kidney disease during COVID-19

    by Mehmet Barlas Uzun, Gizem Gülpınar, Aysel Pehkivanlı, Şule Şengül

    Chronic kidney disease (CKD) is a major public health issue. COVID-19 immensely affects people with chronic diseases including patients with CKD. We aimed to explore the factors that might have an impact on the self-management of patients receiving haemodialysis (HD) and patients with kidney transplant (KTx) during COVID-19 by using the Health Belief Model (HBM). A qualitative phenomenology research design was used to build evidence to establish the effects of the COVID-19 pandemic on self-management behaviour of patients with CKD. Data were analysed using framework analysis to identify key factors influencing patients’ perceptions regarding the self-management of their conditions during COVID-19. Eighteen patients with KTx and seven with HD were interviewed during the lockdown. Having CKD was discussed as a major contributing factor contributing to the perception of susceptibility. The fear of death expressed by the participants had a profound impact on self-management. Delays in check-ups and monitoring, staying at home, financial burden of treatment, lack of trusted information, safety of test sites, and fatalistic attitudes of patients were the barriers identified in the study towards self-management behaviours of patients. External and internal triggers were the motivators of adopting self-management behaviour. This study provides an in-depth view of factors impacting the adoption of self-management behaviour of patients with CKD during COVID-19 and may provide healthcare providers and policymakers knowledge about factors contributing towards compromised patient care.